J. Nicolas, Thérapeutiques en DermatoVénérologie, 2012.

J. Nicolas, Classification des hypersensibilités Maladies autoimmunes et allergiques, 2012.

S. J. Brown, I. Mclean, and W. H. , One Remarkable Molecule: Filaggrin, J Invest Dermatol, vol.132, issue.3, pp.751-62, 2012.

P. Ovaere, S. Lippens, P. Vandenabeele, and W. Declercq, The emerging roles of serine protease cascades in the epidermis, Trends Biochem Sci, vol.34, issue.9, pp.453-63, 2009.

, Collège des enseignants en dermatologie de France. UE revêtement cutané, 2011.

D. Sur,

, Dermatite atopique: diagnostic, évolution, traitement, 2010.

A. Roguedas, L. Machet, V. Fontes, and L. G. , Dermatite atopique : quels sont les critères diagnostiques utilisés dans les articles scientifiques ?, Ann Dermatol Venereol [Internet]. 1 févr, vol.131, issue.2, pp.161-165, 2004.

J. Hanifin and M. Rajka, Diagnostic features of atopic dermatitis, Acta Derm Venereol, vol.92, pp.44-51, 1980.

H. C. Williams, P. G. Burney, R. J. Hay, C. B. Archer, M. J. Shipley et al., Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis, Br J Dermatol

J. Nicolas, A. Rozières, and M. Castelain,

, Ann Dermatol Venereol [Internet], vol.132, issue.HS1, pp.44-52, 2005.

D. Wilsmann-theis, T. Hagemann, J. Jordan, T. Bieber, and N. Novak, Facing psoriasis and atopic dermatitis: are there more similarities or more differences?

, Eur J Dermatol, vol.18, issue.2, pp.172-80, 2017.

. Insermn, Dermatite atopique ou eczéma atopique, 2017.

J. Berbari, S. Reynolds, M. Heil-ruess, and M. Iskedjian, Systematic review of the epidemiologic literature on atopic dermatitis in children. Value Heal

, , vol.14, pp.53-57, 2011.

S. Nutten, Atopic dermatitis: global epidemiology and risk factors, Ann Nutr Metab, vol.66, pp.8-16, 2015.
DOI : 10.1159/000370220

H. Williams, A. Stewart, E. Von-mutius, W. Cookson, and A. Hr, International Study of Asthma and Allergies in Childhood (ISAAC) Phase One and Three Study Groups. Is eczema really on the increase worldwide?, J Allergy Clin Immunol, vol.121, issue.4, pp.947-954, 2008.

. Vidal, Dermatite atopique de l'adulte -Objectifs de la prise en charge

B. Rehal, A. W. Armstrong, and A. W. Armstrong, Health outcome measures in atopic dermatitis: a systematic review of trends in disease severity and quality-of-life instruments 1985-2010. Gluud LL, éditeur. PLoS One, vol.6, p.17, 2017.

J. Schmitt, S. Langan, H. C. Williams, and E. Network, What are the best outcome measurements for atopic eczema? A systematic review, J Allergy Clin Immunol, vol.120, issue.6, pp.1389-98, 2007.

T. Housman, M. Patel, F. Camacho, S. Feldman, A. Fleischer et al., Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: Results of a validation study, Br J Dermatol, vol.147, issue.6, pp.1192-1200, 2002.

F. B. Wolkerstorfer and . De-waard-van-d-a, Scoring the Severity of Atopic Dermatitis: Three Item Severity Score as a Rough System for Daily Practice and as a Pre-screening Tool for Studies, Acta Derm Venereol, vol.79, issue.5, pp.356-365, 2017.

E. A. Holm and G. Jemec, Time Spent on Treatment of Atopic Dermatitis: A New Method of Measuring Pediatric Morbidity? Pediatr Dermatol, vol.21, pp.623-630, 2004.

G. Jemec, S. Esmann, E. A. Holm, A. Tycho, and T. Jørgensen, An independent assessment of disease severity in atopic dermatitis, Acta dermatovenerologica Alpina, vol.15, issue.3, pp.119-143, 2006.

C. R. Charman, A. J. Venn, H. Williams, and M. Bigby, Measuring Atopic Eczema Severity Visually, Arch Dermatol, vol.141, issue.1, p.17, 2005.
DOI : 10.1001/archderm.141.9.1146

URL : https://jamanetwork.com/journals/jamadermatology/articlepdf/398138/dea50001_1146_1151.pdf

I. Angelova-fischer, A. Bauer, U. C. Hipler, I. Petrov, J. Kazandjieva et al., The Objective Severity Assessment of Atopic Dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis, Br J Dermatol, vol.153, issue.1, pp.767-73, 2005.

A. B. Sprikkelman, R. A. Tupker, H. Burgerhof, J. P. Schouten, P. Brand et al., Severity scoring of atopic dermatitis: a comparison of three scoring systems, Allergy, vol.52, issue.1, pp.944-953, 1997.

D. Sur,

K. Carel, D. L. Bratton, N. Miyazawa, E. Gyorkos, K. Kelsay et al., The Atopic Dermatitis Quickscore (ADQ): validation of a new parent-administered atopic dermatitis scoring tool, Asthma Immunol, vol.101, issue.1, pp.500-507, 2008.

M. E. Schram, P. I. Spuls, M. Leeflang, R. Lindeboom, J. D. Bos et al., EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference, Allergy, vol.67, issue.1, pp.99-106, 2012.

D. P. Charman and G. A. Varigos, Grades of severity and the validation of an atopic dermatitis assessment measure (ADAM), J Outcome Meas, vol.3, issue.2, pp.162-75, 1999.

J. Stalder, S. Barbarot, A. Wollenberg, E. A. Holm, L. De-raeve et al., Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe, Allergy [Internet]. 1 août, vol.66, issue.8, pp.1114-1135, 2011.

S. Van-velsen, M. J. Knol, I. M. Haeck, C. Bruijnzeel-koomen, and S. Pasmans, The Self-Administered Eczema Area and Severity Index in Children with Moderate to Severe Atopic Dermatitis: Better Estimation of AD Body Surface Area Than Severity, Pediatr Dermatol, p.17

, , vol.27, pp.470-475, 2017.

M. K. Hill, K. Pishkenari, A. Braunberger, T. L. Armstrong, A. W. Dunnick et al., Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review, J Am Acad Dermatol, vol.75, issue.5, pp.906-923, 2016.

, Lesson on Thermal Burns: The Rule of Nines | Wound Care, 2015.

C. Charman and H. Williams, Outcome Measures of Disease Severity in Atopic Eczema, Arch Dermatol [Internet]. 1 juin, vol.136, issue.6, pp.763-772, 2000.

A. P. Oranje, Practical Issues on Interpretation of Scoring Atopic Dermatitis: SCORAD Index, Objective SCORAD, Patient-Oriented SCORAD and ThreeItem Severity Score, Pathogenesis and Management of Atopic Dermatitis, pp.149-55, 2011.

T. Fredriksson and U. Pettersson, Severe psoriasis--oral therapy with a new retinoid, vol.157, pp.238-282, 1978.

D. Sur,

C. R. Charman, A. J. Venn, and H. C. Williams, Reliability testing of the Six Area, Six Sign Atopic Dermatitis severity score, Br J Dermatol, vol.146, issue.6, pp.1057-60, 2002.

J. Schmitt, P. Spuls, M. Boers, K. Thomas, J. Chalmers et al., Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. (English), Allergy [Internet], vol.67, issue.9, p.17, 2012.

, Toctino (alitretinoïne) : restriction de la prescription aux dermatologues -Lettre aux professionnels de santé, Agence nationale de sécurité du médicament et des produits de santé, p.17, 2017.

L. F. Eichenfield, W. L. Tom, and . Btgkapasskbjncslcdeckdckmddmfsrhjmmdjsraselwhcecabj-hcgbwssr, Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies, J Am Acad Dermatol, vol.71, issue.1, pp.116-148, 2014.

S. Steinke, A. Langenbruch, S. Ständer, N. Franzke, and A. M. , Therapeutic benefits in atopic dermatitis care from the patients' perspective: results of the German national health care study « Atopic Health

L. Lundberg, M. Johannesson, M. Silverdahl, C. Hermansson, and M. Lindberg, Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity, Acta Derm Venereol, vol.80, issue.6, pp.430-434, 2000.

S. Gu, Y. Awh, X. Ccl, L. Cg, C. Pang et al., Review of the studies regarding chinese herbal medicine for atopic eczema, Cochrane Collab, issue.9, 2015.

H. Nankervis, K. S. Thomas, F. M. Delamere, S. Barbarot, N. K. Rogers et al., Scoping systematic review of treatments for eczema, Program Grants Appl Res, vol.4, issue.7, pp.2050-4322, 2016.

L. M. Thøstesen, J. Kjaergaard, G. T. Pihl, N. M. Birk, T. N. Nissen et al.,

, Neonatal BCG vaccination and atopic dermatitis before 13 months of age: A randomized clinical trial, Allergy, issue.9, p.17, 2017.

D. Sur,

. Sanofi, Protocole d'utilisation thérapeutique et de recueil d'informations sur le Dupilumab, p.17, 2017.

. Wanglangplaza, Formule Holly Mangrove Gel, 2017.

L. Drake, M. Prendergast, R. Maher, D. Breneman, N. Korman et al., The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis, J Am Acad Dermatol

M. Napolitano, M. Megna, C. Patruno, P. Gisondi, F. Ayala et al., Adult atopic dermatitis: a review. G Ital Di Dermatologia E Venereol Organo Uff Soc Ital Di Dermatologia E Sifilogr, 2015.

, Atopic dermatitis: Clinical outcomes assessment recommendations, 2017.

R. Schiffner, J. Schiffner-rohe, M. Landthaler, and W. Stolz, Treatment of Atopic Dermatitis and Impact on Quality of Life, Pharmacoeconomics, vol.21, issue.3, pp.159-79, 2003.

L. Finlay and A. Y. , The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use, Br J Dermatol

K. L. Hon, N. H. Pong, T. Poon, D. Chan, T. F. Leung et al., Quality of life and psychosocial issues are important outcome measures in eczema treatment, J Dermatolog Treat, vol.6634, issue.1, pp.83-92, 2014.

P. E. Beattie and L. Ms, A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases, Br J Dermatol, vol.155, issue.1, pp.145-51, 2006.

A. Ahmed, A. Leon, D. C. Butler, and J. Reichenberg, Quality-of-life effects of common dermatological diseases, Semin Cutan Med Surg [Internet], vol.32, issue.2, pp.101-110, 2013.

D. Sur,

A. Torrelo, J. Ortiz, A. Alomar, R. S. Prieto, M. Cuervo et al., Atopic dermatitis: impact on quality of life and patients' attitudes toward its management, Eur J dermatology EJD, vol.22, issue.1, pp.97-105, 2012.

J. Sánchez-pérez, E. Daudén-tello, A. M. Mora, L. Surinyac, and N. , Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: the PSEDA study, Actas Dermosifiliogr [Internet], vol.104, issue.1, pp.44-52, 2013.

C. Yano, H. Saeki, T. Ishiji, Y. Ishiuji, J. Sato et al., Impact of disease severity on sleep quality in Japanese patients with atopic dermatitis, J Dermatol Sci, vol.72, issue.2, pp.195-202, 2013.

J. Schmitt, E. Heese, G. Wozel, and M. Meurer, Effectiveness of inpatient treatment on quality of life and clinical disease severity in atopic dermatitis and psoriasis vulgaris -a prospective study, Dermatology [Internet], vol.214, issue.1, pp.68-76, 2007.

D. Sur,

Y. Finlay-a, Quality of life in atopic dermatitis, J Am Acad Dermatol, vol.45, issue.1, pp.64-70, 2001.

G. Arnold, R. J. Donnelly, A. Altieri, L. Wong, K. S. Sung et al., Assessment of outcomes and parental effect on Quality-of-Life endpoints in the management of atopic dermatitis. Manag Care Interface

S. P. Mckenna, D. Whalley, A. L. Dewar, R. Erdman, T. Kohlmann et al., International development of the Parents' Index of Quality of Life in Atopic Dermatitis (PIQoL-AD), vol.14, pp.231-272, 2005.

C. S. Lapidus and E. Kerr, Social impact of Atopic Dermatitis, Med Heal, vol.84, issue.9, pp.294-299, 2001.

D. Whalley, J. Huels, S. P. Mckenna, D. Van-assche, D. Assche et al., The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents' quality of life in the treatment of pediatric atopic dermatitis, Pediatrics

D. Fivenson, R. Arnold, D. J. Kaniecki, J. L. Cohen, F. Frech et al., The effect of atopic dermatitis on total burden of illness and quality of life on adults and children in a large managed care organization, J Manag Care Pharm [Internet], vol.8, issue.5, pp.333-375, 2002.

W. K. Cheung, .. H. Lee, R. L. , and .. T. , Children and adolescents living with atopic eczema: an interpretive phenomenological study with Chinese mothers, J Adv Nurs, vol.68, issue.10, pp.2247-55, 2012.
DOI : 10.1111/j.1365-2648.2011.05915.x

H. Lee, T. Zuberbier, and M. Worm, Treatment of atopic dermatitis with pimecrolimus -impact on quality of life, Ther Clin Risk Manag [Internet], vol.3, issue.6, pp.1021-1027, 2007.

S. Roll, T. Reinhold, D. Pach, B. Brinkhaus, K. Icke et al., Comparative Effectiveness of Homoeopathic vs. Conventional Therapy in Usual Care of Atopic Eczema in Children: Long-Term Medical and Economic Outcomes

, PLoS One, vol.8, issue.1, pp.1-9, 2013.

C. M. Witt, B. Brinkhaus, D. Pach, T. Reinhold, K. Wruck et al., Homoeopathic versus conventional therapy for atopic eczema in children: Medical and economic results, Dermatology [Internet], vol.219, issue.4, pp.329-369, 2009.
DOI : 10.1159/000248854

N. Novak, D. Thaci, M. Hoffmann, R. Fölster-holst, T. Biedermann et al., Subcutaneous immunotherapy with a depigmented polymerized birch pollen extract--a new therapeutic option for patients with atopic dermatitis. Int Arch Allergy Immunol, vol.155, pp.252-258, 2011.

L. R. Daud, M. E. Garralda, and T. J. David, Psychosocial adjustment in preschool children with atopic eczema, Arch Dis Child [Internet], vol.69, issue.6, pp.670-676, 1993.
DOI : 10.1136/adc.69.6.670

URL : http://europepmc.org/articles/pmc1029652?pdf=render

D. Sur,

S. Farina, P. Gisondi, M. Zanoni, M. Pace, L. Rizzoli et al.,

, Balneotherapy for atopic dermatitis in children at Comano spa in Trentino, Italy, J Dermatolog Treat [Internet], vol.22, issue.6, pp.366-71, 2011.

P. Chernyshov, L. Kaliuzhna, A. Reznikova, and M. Basra, Comparison of the impairment of family quality of life assessed by disease-specific and dermatology-specific instruments in children with atopic dermatitis. J Eur Acad Dermatology Venereol, vol.29, pp.1221-1225, 2014.

D. Sur,

A. Shobaili and H. , The impact of childhood atopic dermatitis on the patients' family, Pediatr Dermatol [Internet], vol.27, issue.6, pp.618-641, 2010.

M. Aziah, T. Rosnah, A. Mardziah, and M. Z. Norzila, Childhood atopic dermatitis: a measurement of quality of life and family impact, Med J Malaysia

J. C. Su, A. S. Kemp, G. A. Varigos, and T. M. Nolan, Atopic eczema: its impact on the family and financial cost, Arch Dis Child [Internet]. févr, vol.76, issue.2, pp.159-62, 1997.
DOI : 10.1136/adc.76.2.159

URL : http://europepmc.org/articles/pmc1717083?pdf=render

D. Sur,

N. Jenner, J. Campbell, and R. Marks, Morbidity and cost of atopic eczema in Australia, Australas J Dermatol [Internet], vol.45, issue.1, pp.16-22, 2004.

K. S. Thomas, K. Koller, T. Dean, C. J. O'leary, T. H. Sach et al., A multicentre randomised controlled trial and economic evaluation of ionexchange water softeners for the treatment of eczema in children: the Softened Water Eczema Trial (SWET). Health Technol Assess, vol.15, pp.1-156, 2011.

C. Mercier and P. Corten, Évaluation de la qualité de vie en psychiatrie, pp.263-87, 1994.

D. Karnofsky and J. Bourchnal, The clinical evaluation of chemotherapeutic agents in cancer, Eval Chemother agents, 1949.

M. Katz and S. Lyerly, Methods for measuring adjustement and social behavior in the community, Psychol Reports J, 1963.

R. Berg, D. Hallaner, and C. Berck, Neglected aspects of the quality of life, Health Serv Res, vol.2, pp.391-396, 1976.

S. Levine and S. Croog, What constitute quality of life? A conceptualization of dimensions of life quality in healthy populations and patients with cardiovascular disease, pp.46-58, 1984.

S. Katz, The science of quality of life, J Chronic Dis, vol.40, issue.6, pp.459-63, 1987.

, The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization, Social science & medicine, 1982.

A. G. Campolina and R. M. Ciconelli, Qualidade de vida e medidas de utilidade: parâmetros clínicos para as tomadas de decisão em saúde. Rev Panam Salud Pública, vol.19, pp.128-164, 2006.

L. , Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema, Int J Clin Pract, vol.12, issue.2006, pp.984-92, 2017.

S. H. Oh, B. K. Bae, T. G. Kim, Y. S. Kwon, J. H. Lee et al., Effective treatment of facial redness caused by atopic dermatitis using intense pulsed light systems

D. Surg, , vol.36, pp.475-82, 2010.

P. Chernyshov, A. Jirakova, R. Ho, H. Moed, A. P. Caldeira et al., An international multicenter study on quality of life and family quality of life in children with atopic dermatitis, Indian J Dermatol Venereol Leprol [Internet], vol.79, issue.1, pp.52-60, 2013.

S. R. Dodington, M. K. Basra, F. A. Salek, and M. S. , The Dermatitis Family Impact questionnaire: A review of its measurement properties and clinical application, Br J Dermatol, vol.169, issue.1, pp.31-46, 2013.

C. S. Lapidus, Role of social factors in atopic dermatitis: the US perspective, J Am Acad Dermatol, vol.45, pp.41-43, 2001.

H. Van-os-medendorp, H. Koffijberg, E. Kok, P. Van-der-zalm, A. et al., E-health in caring for patients with atopic dermatitis: A randomized controlled cost-effectiveness study of internetguided monitoring and online self-management training, Br J Dermatol [Internet], vol.166, issue.5, pp.1060-1068, 2012.

D. Staab, R. Kaufmann, M. Bräutigam, U. Wahn, and C. Group, Treatment of infants with atopic eczema with pimecrolimus cream 1% improves parents' quality of life: a multicenter, randomized trial. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol, vol.16, pp.527-560, 2005.

F. C. Beikert, A. K. Langenbruch, M. A. Radtke, T. Kornek, S. Purwins et al., Willingness to pay and quality of life in patients with atopic dermatitis, Arch Dermatol Res, vol.306, issue.3, pp.279-86, 2014.

M. Basra, V. Gada, S. Ungaro, F. A. Salek, and S. M. , Infants' Dermatitis Quality of Life Index: A decade of experience of validation and clinical application, Br J Dermatol, vol.169, issue.4, pp.760-768, 2013.

S. B. Dertlio?lu, D. Cicek, D. D. Balci, N. Halisdemir, S. B. Dertlio?lu et al., Dermatology life quality index scores in children with vitiligo: comparison with atopic dermatitis and healthy control subjects, Int J Dermatol

G. Schmid-ott, H. W. Kuensebeck, B. Jaeger, T. Werfel, K. Frahm et al., Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients, Acta Derm Venereol, vol.79, issue.6, pp.443-450, 1999.

S. Manzoni-apd-da, M. B. Weber, S. Nagatomi-ar-da, R. L. Pereira, R. Z. Townsend et al., Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders, An Bras Dermatol, vol.88, issue.6, pp.894-903, 2013.

P. Warschburger, H. T. Buchholz, and F. Pertermann, Psychological adjustment in parents of young children with atopic dermatitis: which factors predict parental quality of life?, Br J Dermatol [Internet], vol.150, pp.304-315, 2004.

A. Evers, Y. Lu, P. Duller, P. Van-der-valk, F. W. Kraaimaat et al., Common burden of chronic skin diseases? Contributors to psychological distress in adults with psoriasis and atopic dermatitis, Br J Dermatol [Internet], vol.152, issue.6, pp.1275-81, 2005.

A. Evers, P. Duller, P. Van-de-kerkhof, P. Van-der-valk, E. De-jong et al., The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument, Br J Dermatol, issue.12, p.20, 2007.

R. M. Herd, M. J. Tidman, D. A. Ruta, and J. A. Hunter, Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods, Br J Dermatol, vol.136, issue.4, pp.502-509, 1997.

T. Zuberbier, S. J. Orlow, A. S. Paller, A. Taïeb, R. Allen et al., Patient perspectives on the management of atopic dermatitis, J Allergy Clin Immunol, vol.118, issue.1, pp.226-258, 2006.

L. Misery, A. Y. Finlay, N. Martin, S. Boussetta, C. Nguyen et al., Atopic dermatitis: impact on the quality of life of patients and their partners, Dermatology [Internet], vol.215, issue.2, pp.123-132, 2007.

S. Coghi, M. C. Bortoletto, S. Sampaio, .. P. , A. Junior et al., Quality of life is severely compromised in adult patients with atopic dermatitis in

. Brazil, Clinics

M. Kawashima and S. Harada, Effect of standard medication on quality of life of patients with atopic dermatitis, J Dermatol [Internet], vol.34, issue.1, pp.9-16, 2007.

D. Sur,

J. Linnet and G. B. Jemec, An assessment of anxiety and dermatology life quality in patients with atopic dermatitis, Br J Dermatol [Internet], vol.140, issue.2, pp.268-72, 1999.

D. Sur,

M. S. Salek, A. Y. Finlay, D. K. Luscombe, B. R. Allen, J. Berth-jones et al., Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial, Br J Dermatol, vol.129, pp.422-452, 1993.

J. J. Grob, J. Revuz, J. P. Ortonne, P. Auquier, and L. G. , Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life

, Br J Dermatol, vol.152, issue.2, pp.289-95, 2005.

M. Kawashima and Q. Dermatitis, Quality of life in patients with atopic dermatitis: impact of tacrolimus ointment, Int J Dermatol [Internet], vol.45, issue.6, pp.731-737, 2006.

S. L. Chamlin, I. J. Frieden, M. L. Williams, and M. Chren, Effects of Atopic Dermatitis on Young American Children and Their Families, Pediatrics, vol.114, issue.3, pp.607-618, 2004.

T. Schäfer, A. Staudt, and J. Ring, Deutsches Instrument zur Erfassung der Lebensqualität bei Hauterkrankungen (DIELH), Der Hautarzt, vol.52, issue.7, pp.624-632, 2001.

A. Y. Finlay and G. K. Khan, Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use, Clin Exp Dermatol

, , vol.19, pp.210-216, 1994.

H. Granlund, P. Erkko, and S. Reitamo, Comparison of the influence of cyclosporine and topical betamethasone-17,21-dipropionate treatment on quality of life in chronic hand eczema, Acta Derm Venereol, vol.77, issue.1, pp.54-62, 1997.

G. Ricci, B. Bendandi, F. Bellini, A. Patrizi, and M. Masi, Atopic dermatitis: quality of life of young Italian children and their families and correlation with severity score. Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol, vol.18, pp.245-254, 2007.

, Impact of atopic dermatitis on the quality of life of Saudi children, Saudi Med J [Internet], vol.35, issue.4, pp.391-397, 2014.

C. Coutanceau and J. Stalder, Analysis of correlations between patient-oriented SCORAD (PO-SCORAD) and other assessment scores of atopic dermatitis severity and quality of life, Dermatology [Internet], vol.229, issue.3, pp.248-55, 2014.

D. Sur,

K. Hon, T. F. Leung, P. C. Ng, M. Lam, W. Kam et al., Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study, Br J Dermatol [Internet], vol.157, issue.2, pp.357-63, 2007.

K. L. Hon, Y. Tsang, N. H. Pong, D. Luk, V. W. Lee et al., Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema, J Dermatolog Treat

M. Van-oosterhout, S. R. Janmohamed, M. Spierings, J. Hiddinga, F. B. De-waard-van-der-spek et al., Correlation between Objective SCORAD and ThreeItem Severity Score used by physicians and Objective PO-SCORAD used by parents/patients in children with atopic dermatitis, Dermatology

I. M. Haeck, O. Ten-berge, S. Van-velsen, M. S. De-bruin-weller, C. Bruijnzeelkoomen et al., Moderate correlation between quality of life and disease activity in adult patients with atopic dermatitis. J Eur Acad Dermatology Venereol JEADV, vol.26, pp.236-277, 2012.

R. Van-valburg, M. G. Willemsen, P. C. Dirven-meijer, A. P. Oranje, J. C. Van-der-wouden et al., Quality of life measurement and its relationship to disease severity in children with atopic dermatitis in general practice, Acta Derm Venereol [Internet], vol.91, issue.2, pp.147-51, 2011.

K. E. Hon, K. Y. Wong, T. Leung, C. Chow, and P. Ng, Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis, Am J Clin Dermatol [Internet], vol.9, issue.1, pp.45-50, 2008.

K. Hon, W. Kam, M. Lam, T. F. Leung, P. C. Ng et al., Are they Correlated? Qual Life Res, vol.15, pp.1551-1559, 2006.

G. Ricci, B. Bendandi, L. Pagliara, A. Patrizi, and M. Masi, Atopic dermatitis in Italian children: evaluation of its economic impact, J Pediatr Heal Care, vol.20, issue.5, pp.311-316, 2006.

K. Hon, T. F. Leung, K. Y. Wong, C. M. Chow, A. Chuh et al., Does age or gender influence quality of life in children with atopic dermatitis?, Clin Exp Dermatol, vol.33, issue.6, pp.705-714, 2008.

E. Group, EQ-5D-5L description, 2017.

D. Sur,

J. Bostoen, S. Bracke, D. Keyser, S. Lambert, and J. , An educational programme for patients with psoriasis and atopic dermatitis: a prospective randomized controlled trial, Br J Dermatol, vol.167, issue.5, pp.1025-1056, 2012.

U. Åkerström, S. Reitamo, T. Langeland, M. Berg, L. Rustad et al., Comparison of Moisturizing Creams for the Prevention of Atopic Dermatitis Relapse: A Randomized Double-blind Controlled Multicentre Clinical Trial, Acta Derm Venereol [Internet], vol.95, issue.5, pp.587-92, 2015.

G. Kiebert, S. Sorensen, D. Revicki, S. C. Fagan, J. J. Doyle et al.,

, Atopic dermatitis is associated with a decrement in health-related quality of life

J. Int and . Dermatol, , vol.41, pp.151-159, 2002.

E. A. Holm, H. C. Wulf, H. Stegmann, and G. Jemec, Life quality assessment among patients with atopic eczema, Br J Dermatol [Internet], vol.154, issue.4, pp.719-744, 2006.

D. Sur,

C. D. Poole, C. Chambers, R. Allsopp, and C. J. Currie, Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids. J Eur Acad Dermatology Venereol JEADV, Internet], vol.24, issue.6, pp.674-682, 2010.

C. D. Poole, C. Chambers, M. K. Sidhu, and C. J. Currie, Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study, Br J Dermatol [Internet], vol.161, issue.6, pp.1335-1375, 2009.

S. Holme, I. Man, and J. Sharpe, The Children's Dermatology Life Quality Index: validation of the cartoon version, Br J Dermatol, vol.148, issue.2, pp.285-90, 2003.

. Torrelo-a, J. Ortiz, A. A. , R. S. Pedrosa, E. Cuervo et al., Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study, Actas Dermosifiliogr [Internet], vol.104, issue.5, pp.409-426, 2013.

K. Kim and T. Kono, Overview of efficacy and safety of tacrolimus ointment in patients with atopic dermatitis in Asia and other areas, Int J Dermatol, vol.50, issue.9, pp.1153-61, 2011.

I. Wang and J. Wang, Children with atopic dermatitis show clinical improvement after Lactobacillus exposure, Clin Exp Allergy J Br Soc Allergy Clin Immunol [Internet], vol.45, issue.4, pp.779-87, 2015.

S. Reitamo and R. Allsopp, Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: results from two randomized, multicentre, comparative studies, J Dermatolog Treat [Internet], vol.21, issue.1, pp.34-44, 2010.

C. Flohr and A. D. Irvine, Systemic therapies for severe atopic dermatitis in children and adults, J Allergy Clin Immunol [Internet], vol.132, issue.3, pp.774-774, 2013.

D. Sur,

N. Onumah and L. Kircik, Pimecrolimus cream and tacrolimus ointment in the treatment of atopic dermatitis: A pilot study on patient preference, J Drugs Dermatology [Internet], vol.12, issue.10, pp.1145-1153, 2013.

M. T. Woods, P. A. Brown, S. F. Baig-lewis, and E. L. Simpson, Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis, J Drugs Dermatology, vol.10, issue.2, pp.171-177, 2011.

D. Becker, E. Langer, M. Seemann, G. Seemann, I. Fell et al., Clinical efficacy of blue light full body irradiation as treatment option for severe atopic dermatitis, PLoS One, vol.6, issue.6, pp.1-9, 2011.

M. Boguniewicz, W. Abramovits, A. Paller, D. L. Whitaker-worth, M. Prendergast et al., A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis, J Drugs Dermatology, vol.6, issue.4, pp.416-439, 2007.

M. Meurer, R. Fölster-holst, G. Wozel, G. Weidinger, M. Jünger et al., Pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study, Dermatology [Internet], vol.205, issue.3, pp.271-278, 2002.

D. Sur,

J. G. Holm, T. Agner, M. Clausen, and S. F. Thomsen, Quality of life and disease severity in patients with atopic dermatitis, J Eur Acad Dermatology, vol.30, issue.10, pp.1760-1767, 2016.

W. Czech, M. Bräutigam, G. Weidinger, and E. Schöpf, A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life, J Am Acad Dermatol, vol.42, issue.4, pp.653-662, 2000.

T. Ruzicka, C. Willers, and W. Wigger-alberti, Efficacy and patient-reported outcomes of a new mometasone cream treating atopic eczema, Skin Pharmacol Physiol, vol.25, issue.6, pp.305-317, 2012.

N. Novak, T. Bieber, M. Hoffmann, R. Fcolster-holst, B. Homey et al., Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis, J Allergy Clin Immunol, vol.130, issue.4, 2012.

S. Cho, M. Kim, J. Kim, J. Park, and D. Nahm, Clinical efficacy of autologous plasma therapy for atopic dermatitis, Dermatology [Internet], vol.228, issue.1, pp.71-78, 2014.

Y. Panahi, S. M. Davoudi, N. Madanchi, and E. Abolhasani, Recombinant human interferon gamma (Gamma Immunex) in treatment of atopic dermatitis, Clin Exp Med [Internet], vol.12, issue.4, pp.241-246, 2012.

A. Samrao, T. M. Berry, R. Goreshi, and E. L. Simpson, A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults, Arch Dermatol [Internet]. août, vol.148, issue.8, pp.890-897, 2012.

M. E. Schram, E. Roekevisch, M. Leeflang, J. D. Bos, J. Schmitt et al., A randomized trial of methotrexate versus azathioprine for severe atopic eczema

, J Allergy Clin Immunol [Internet], vol.128, issue.2, pp.353-362, 2011.

D. Belilovsky, C. Roo-rodriguez, E. Baudouin, C. Menu, F. Chadoutaud et al., Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis, J Dermatolog Treat [Internet]. déc, vol.22, issue.6, pp.359-65, 2011.

A. M. Edwards, D. Bibawy, S. Matthews, N. Tongue, S. H. Arshad et al., Long-term use of a 4% sodium cromoglicate cutaneous emulsion in the treatment of moderate to severe atopic dermatitis in children, J Dermatolog Treat [Internet], pp.1-7, 2015.

F. Gayraud, M. Sayag, and J. E. , Efficacy and tolerance assessment of a new type of dermocosmetic in infants and children with moderate atopic dermatitis

, J Cosmet Dermatol, pp.1-6, 2015.

S. H. Wu, X. Q. Chen, B. Liu, H. J. Wu, and L. Dong, Efficacy and safety of 15(R/S)-methyl-lipoxin A4 in topical treatment of infantile eczema, Br J Dermatol, vol.168, issue.1, pp.172-180, 2013.

S. Darné, S. N. Leech, and T. A. Em, Narrowband ultraviolet B phototherapy in children with moderate-to-severe eczema: a comparative cohort study, Br J Dermatol, vol.170, issue.1, pp.150-156, 2014.

M. Futamura, I. Masuko, K. Hayashi, Y. Ohya, and K. Ito, Effects of a short-term parental education program on childhood atopic dermatitis: a randomized controlled trial, Pediatr Dermatol [Internet], vol.30, issue.4, pp.438-481, 2013.

D. M. Meads, S. P. Mckenna, and K. Kahler, The quality of life of parents of children with atopic dermatitis: interpretation of PIQoL-AD scores. Qual Life Res An Int J Qual Life Asp Treat Care Rehabil, vol.14, pp.2235-2280, 2005.

B. G. Bender, R. Ballard, B. Canono, J. R. Murphy, and D. Leung, Disease severity, scratching, and sleep quality in patients with atopic dermatitis, J Am Acad Dermatol, vol.58, issue.3, pp.415-435, 2008.

R. M. Emerson, H. C. Williams, B. R. Allen, R. Mehta, and A. Y. Finlay, Summaries of Papers : How much disability does atopic eczema cause compared with other common childhood health problems ?, Br J Dermatol, vol.137, issue.S50, p.19, 1997.

J. Chevalier, Mesure de l'utilité attachée aux états de santé. Valorisation de l'index d'utilité EQ-5D et évolution de l'échelle actuelle en France

P. Dauphine and ;. , , 2010.

K. L. Hon, W. Lo, W. Cheng, T. Leung, C. Chow et al., Prospective self-controlled trial of the efficacy and tolerability of a herbal syrup for young children with eczema, J Dermatolog Treat